Valuation: CROSSJECT

Market Cap 8.24Cr 9.49Cr 7.69Cr 7.06Cr 13Cr 903Cr 13Cr 91Cr 35Cr 451.4Cr 36Cr 35Cr 1.5TCr P/E 2026 *
3.69x
P/E 2027 * 2.91x
Enterprise Value 6.45Cr 7.43Cr 6.02Cr 5.53Cr 10Cr 706.9Cr 11Cr 71Cr 28Cr 353.37Cr 28Cr 27Cr 1.17TCr EV / Sales 2026 *
1.06x
EV / Sales 2027 * 0.84x
Free-Float
90.34%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%+11.56%-34.72%-55.96% 10Cr
-0.48%+4.02%+92.79%+10.53% 8.04Cr
Average -0.56%+8.64%+29.04%-22.72% 9.24Cr
Weighted average by Cap. -0.58%+9.38%+20.76%-27.03%

Financials

2026 *2027 *
Net sales 6.08Cr 7Cr 5.67Cr 5.21Cr 9.85Cr 666.07Cr 9.96Cr 67Cr 26Cr 332.96Cr 26Cr 26Cr 1.1TCr 4.23Cr 4.87Cr 3.94Cr 3.62Cr 6.85Cr 463.4Cr 6.93Cr 46Cr 18Cr 231.65Cr 18Cr 18Cr 767.54Cr
Net income 2.83Cr 3.26Cr 2.64Cr 2.42Cr 4.58Cr 310.03Cr 4.63Cr 31Cr 12Cr 154.98Cr 12Cr 12Cr 513.51Cr 77.5L 89.25L 72.26L 66.38L 1.26Cr 85Cr 1.27Cr 8.52Cr 3.33Cr 42Cr 3.35Cr 3.28Cr 140.63Cr
Net Debt -1.79Cr -2.06Cr -1.67Cr -1.53Cr -2.9Cr -196.09Cr -2.93Cr -20Cr -7.69Cr -98Cr -7.74Cr -7.57Cr -324.8Cr -4.7Cr -5.41Cr -4.38Cr -4.03Cr -7.61Cr -514.89Cr -7.7Cr -52Cr -20Cr -257.38Cr -20Cr -20Cr -852.83Cr
Logo CROSSJECT
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-